Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “calcium”

95 pharma patents match "calcium" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 95
Index total 30,257
Page 3 / 4

Quick answer

This filtered view shows 95 pharmaceutical patents matching "calcium" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

95 results for “calcium” · 30,257 patents in full index Clear search

  1. US 8642081

    Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance

    TAKEDA NYCOMED AS · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted
  2. US 8618058

    Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

    Soricimed Biopharma Inc. · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted
  3. US 8501727

    Short acting benzothiazepine calcium channel blockers and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  4. US 8388930

    Diagnosis and assessment of skeletal related disease using calcium 41

    The Regents of the University of California · Granted Mar 5, 2013 · Expires Feb 28, 2033

    granted
  5. US 8216614

    Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis

    The Board of Regents of the University of Texas System · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted
  6. US 8211857

    Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

    Soricimed Biopharma Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  7. US 8211935

    Heterocyclic derivatives for modulation of calcium channels

    Vertex Pharmaceuticals Incorporated · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  8. US 8178076

    Diagnosis and assessment of skeletal related disease using calcium 41

    The Regents of the University of California · Granted May 15, 2012 · Expires May 10, 2032

    granted
  9. US 2012029034

    Novel calcium salts of Compound as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents

    AMMENDOLA ALDO [DE] · Granted Feb 2, 2012 · Expires Jan 28, 2032

    granted
  10. US 8080672

    Crystal form of atorvastatin hemi-calcium and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  11. US 8007778

    Use of calcium binding proteins to improve cardiac contractile function

    The Regents of the University of California · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted
  12. US 7994178

    Crystalline rosuvastatin calcium and compositions thereof for treatment of hyperlipidaemia

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted
  13. US 7888384

    Heterocyclic derivatives for modulation of calcium channels

    Vertex Pharmaceuticals Incorporated · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted
  14. US 7737177

    Processes for preparing crystalline and amorphous mupirocin calcium

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Jun 15, 2010 · Expires Jun 10, 2030

    granted
  15. US 7674923

    Process for preparing forms of atorvastatin calcium substantially free of impurities

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted
  16. US 7662820

    Dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon

    SanRx Pharmaceuticals, Inc. · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted
  17. US 7629005

    Pharmaceutical formulation consisting of a plant dry extract with a calcium coating

    Bionorica AG · Granted Dec 8, 2009 · Expires Dec 3, 2029

    granted
  18. US 7569604

    Heterocyclic derivatives for modulation of calcium channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted
  19. US 7514441

    Substituted pyrazolo [1,5-A]pyrimidines as calcium receptor modulating agents

    Takeda Pharmaceutical Company Limited · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted
  20. US 7501450

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted
  21. US 7488750

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted
  22. US 7468444

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted
  23. US 7456297

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted
  24. US 7396927

    Process for preparation of rosuvastatin calcium

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted